On my outpatient clinical rotations last year, I saw ample management of heart disease and smoking cessation counseling. I also saw the annual physicals and checkups. But what surprised me was how many patients were on medications that were just now be…
If she grabs the baton from President Joe Biden to become the new presumptive Democratic presidential nominee, Kamala Harris would widely be expected to take an aggressive stance in support of abortion access — hitting former President Donald Trump on an issue that could undermine his chances of victory.
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Join us as we sit down with writer Robin D’Amato to discuss her book, Sugar-Free. Robin delves into the inspiring journey of Ginny Eastman, a girl whose passion for …
Since the United States Food and Drug Administration approved exenatide in 2005, it took decades for the American Society of Anesthesiologists (ASA) to identify and address perioperative safety concerns, if any, among patients using glucagon-like pepti…
A debate marked by President Joe Biden’s faltering performance featured clashes over insulin costs, inflation, abortion, immigration, and Jan. 6.
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! We’re joined by Karla Lester, a pediatrician and certified life and weight coach. Together, we explore the journey of Lizzie and her mother, Jackie, as they navigate…
I waited in line at the pharmacy, a familiar chain store. The man in front of me waited patiently for the technician to ring up his meds. I overheard her say to him, “$125.00. That includes your insulin.” The man bowed his head and smiled p…
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Join us for a discussion on the critical intersection of diabetes and liver disease. Our guest, Sarah Bauer, a pediatrician, shares her personal journey and insights into …
Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data. Wegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace…
In this special sponsored episode from Sanofi, we welcome Jennifer Goldman. She is a professor of pharmacy at the Massachusetts College of Pharmacy and Health Sciences, board-certified in advanced diabetes management, and a certified diabetes care and …
